Cameron R. Wolfe

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

Timothy M. Uyeki, Henry H. Bernstein, John S. Bradley et al. · Clinical Infectious Diseases · 2018 · 772 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

Timothy M. Uyeki, Henry H. Bernstein, John S. Bradley et al. · Clinical Infectious Diseases · 2019 · 412 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · Science Translational Medicine · 2021 · 361 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Molnupiravir, an Oral Antiviral Treatment for COVID-19

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · medRxiv · 2021 · 218 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16